Quantcast

Latest Glycated hemoglobin Stories

2014-04-30 10:46:20

Clinical Therapeutics features a special report in its April issue focusing primarily on the behavioral issues associated with patients’ self-management of type 2 diabetes. “Diabetes, perhaps more so than any other chronic disease, requires people to significantly modify their behaviors—sometimes in ways that are contrary to their cultural norms and backgrounds—even when they don’t ‘feel’ sick or experience symptoms of the disease,” said John G. Ryan, Dr.PH., Topic Editor for...

2014-04-24 12:30:30

DUBLIN, April 24, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jwng9z/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Monitoring - Global Strategic Business Report" [http://www.researchandmarkets.com/research/jwng9z/hemoglobin_a1c ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ Million...

2014-04-23 12:29:24

Program Also Led to Better Blood Glucose Control and Greater Reductions in Heart Disease Risk Factors; Jenny Craig for Type 2 Now Available to Consumers CARLSBAD, Calif., April 23, 2014 /PRNewswire/ -- Study Highlights: -- After one year, Jenny Craig participants lost more than three times as much weight as the Usual Care group. -- Study participants following Jenny Craig's lower carbohydrate menu significantly reduced their HbA1c levels from 7.3% to 6.6%, while...

2014-04-23 08:31:57

Stage and Screen Star Shines a Spotlight on Better Blood Sugar Management With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J., April 23, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it is teaming up with Emmy and Golden Globe-winning actress S. Epatha Merkerson on America's Diabetes Challenge: Get to Your Goals, an educational program intended to encourage people with type 2 diabetes to...

Diabetes, Pre-Diabetes Cases Have Doubled Over Twenty Years
2014-04-16 03:00:23

Johns Hopkins Bloomberg School of Public Health Alarming Increases in Blacks, Hispanics and the Elderly; Obesity Partly to Blame Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge. The researchers also found that the burden of the disease has not hit all groups equally, with alarming increases in diabetes in blacks, Hispanics...

2014-04-15 23:12:19

Avail is conducting a 6-week, Phase 2 randomized study to assess the safety, tolerability and pharmacodynamics of a new combination therapy administered to participants with type 2 diabetes mellitus. DeLand, FL (PRWEB) April 15, 2014 *To see if you qualify for this Diabetes Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance required, and you may receive...

2014-04-14 12:34:30

New Abbott test could help physicians diagnose people in the U.S. who are unaware that they have diabetes, empowering them to control their disease ABBOTT PARK, Ill., April 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test - which can aid physicians in diagnosing and monitoring diabetes and identifying people at risk for the disease - has received 510(k) clearance from the U.S. Food and Drug...

2014-04-14 12:32:44

Conference Call and Webcast at 8:30 a.m. Eastern Time THE WOODLANDS, Texas, April 14, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1 diabetes, which achieved the primary endpoint of reducing mealtime insulin use as well as several secondary endpoints, including improved glycemic control. LX4211 is an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2...

2014-04-03 12:23:34

Sleep apnea has been linked with elevated blood sugar levels, suggesting people with the condition could be at an increased risk of cardiovascular illness and mortality. The findings of a new study, published online today (3 April 2014) in the European Respiratory Journal, add to a growing body of evidence that suggests that sleep apnea is linked with diabetes. The research analyzed 5,294 participants from the multinational European Sleep Apnoea Cohort. The researchers measured levels...

2014-04-01 08:28:59

-Promising first interim phase 3 data for ITCA 650 in type 2 diabetes, combined with robust execution against key milestones and the addition of key talent BOSTON, April 1, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the completion of another landmark private round of equity financing for $200 million. Together with the $210 million round of equity and debt financing in November of 2012 the company is very strongly positioned for future milestones and launch...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related